Display Settings:

Format

Send to:

Choose Destination
    New Microbiol. 2009 Apr;32(2):153-8.

    Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.

    Source

    Medical Faculty of Trakya University, Department of Clinical Microbiology and Infectious Diseases, Edirne, Turkey.

    Abstract

    Mutations in the pyrazinamidase (PZase) gene (pncA) are considered the major mechanism of pyrazinamide (PZA) resistance in Mycobacterium tuberculosis. The aim of this study was designed to determine pncA mutations among ten PZA resistant and two PZA susceptible M. tuberculosis strains from Turkey and also to compare the PZase activity of them with the genotype. All isolates were identified by BACTEC NAP (P-nitro-alpha-acetylamino-beta-hydroxy-propiophenone) test and PCR-RFLP (Polymerase Chain Reaction- Restriction Fragment Length Polymorphism) method. Drug sensitivity tests were performed by BACTEC system. PncA mutations were detected by DNA sequence analysis. No mutation was detected in two PZA susceptible and three out of ten PZA resistant strains. While, two of the PZA resistant strains had mutations in the same region (Gly24Asp), two of the PZA resistant strains had mutations in different regions (Thr160Lys), (His51Pro). Three of the PZA resistant strains had frameshift as a 167 bp deletion at nucleotide position 102. As a result, we detected two new mutations and a frameshift which may be responsible for PZA resistance in this study different from the other studies which previously 51st codon mutation was reported.

    PMID:
    19579692
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for Italian Society for Medical, Odontoiatric, and Clinical Microbiology

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk